Skip to the main content.
Facebook Instagram Linkedin X YouTube Medium

megamenu-services

 

Turn Vision into Velocity with the Innovation CRO

Traditional CROs fragment device development with costly hand-offs and learning curves. Veranex unites the essential disciplines for medical device & diagnostic development under one roof from sketch to evidence-generation to market launch.

All connected. All aligned. All accelerating your path to market—delivering breakthrough devices and diagnostics that improve patient lives sooner.

Explore our Services

megamenu-solutions-expertise

 

Outcome-Driven Solutions for Medtech Challenges

Breakthrough innovation requires more than great solutions; it demands deep expertise and insight. Veranex packages outcome-driven solutions with 25+ years of specialized knowledge across major medtech categories, delivering integrated capabilities that solve your most pressing challenges faster and with greater certainty.

Purpose-built solutions. Proven results. User & Patient-centered innovation.

 

Solutions

Expertise

megamenu-company-2

 

Purpose-Built for Breakthroughs

Whether you're transforming patient care or disrupting entire therapeutic categories, innovation requires more than great science, it demands velocity.  Veranex was founded to bridge the gap between visionary concepts and market reality, combining proven expertise with agile execution to accelerate the innovations that matter most.  

We are the Innovation CRO.

Legacy of excellence. Proven execution. Patient impact accelerated.

 

Explore our Company

1 min read

Addressing Heart Failure with IFPx

Gary Keeler : Mar 24, 2025 10:22:43 PM

Addressing Heart Failure with IFPx

Recently two Veranex employees volunteered their time and expertise to IFPx — a company working on a device to monitor and proactively treat heart failure. The team worked to improve UX/UI and refine IFPx’s interstitial implant which monitors pressure that can inform clinicians of impending cardiac conditions.

IFPx is one of just 61 companies selected to take part in the MedTech Innovator 2023 cohort, which had approximately 1,150 applicants this year. MedTech Innovator is the world’s largest accelerator of medical technology companies today, awarding $800,000 in non-dilutive funding to winners of its competitions throughout the 2023 program.

A multi angle image of a medical device concept

“The 2023 MedTech Innovator Cohort once again includes passionate MedTech entrepreneurs from around the globe. We look forward to working with our corporate partners and industry advisors over the course of the program, to help these startups advance their medical device, diagnostic and digital health innovations to improve patient care.”

– Paul Grand, CEO and founder of MedTech Innovator

Study Co-Authored by Veranex Found that Mobile Cardiac Outpatient Telemetry (MCOT) was Associated with Lower Readmissions and Healthcare Costs in Post-Stroke Monitored Patients, Compared to Implantabl

Veranex : Mar 24, 2025 10:23:06 PM

This study compares the health and economic outcomes of using mobile cardiac outpatient telemetry (MCOT) and implantable loop recorders (ILRs)...

Commercialization
Read More

Veranex Supports Philips Healthcare with Writing Manuscript of Medicare Claims Study of Mobile Cardiac Monitoring

admin.veranex : Mar 24, 2025 10:23:08 PM

By leading the manuscript development, Veranex supported Philips Healthcare in publishing real-world evidence data supporting the use of Mobile...

Commercialization
Read More

Recent Study Co-authored by Veranex Researchers collaborating with a leading U.S. Ophthalmology Practice Highlights Real-World Workflow Efficiencies of Cloud-based Surgical Planning Software in Catara

Gary Keeler : Mar 24, 2025 10:22:45 PM

A research team led by Veranex researchers and a leading U.S, ophthalmology practice recently published results from a real-world time-and-motion...

Commercialization
Read More